✦ LIBER ✦

Efficacy of combination therapy with interferon and azidothymidine in chronic type C hepatitis: A pilot study

✍ Scribed by Mikihiro Tsutsumi; Akira Takada; Makoto Sawada

Publisher: Springer Japan
Year: 1995
Tongue: English
Weight: 773 KB
Volume: 30
Category: Article
ISSN: 0944-1174
DOI: 10.1007/bf02347565

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of combination therapy of inter

Efficacy of combination therapy of interferon-α with ursodeoxycholic acid in chronic hepatitis C: A randomized controlled clinical trial

✍ Shinichi Kiso; Sumio Kawata; Shinji Tamura; Yasuharu Imai; Yoshiaki Inui; Toshih 📂 Article 📅 1997 🏛 Springer Japan 🌐 English ⚖ 694 KB

Efficacy of re-treatment with pegylated

Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan

✍ Tsugiko Oze; Naoki Hiramatsu; Takayuki Yakushijin; Kiyoshi Mochizuki; Masahide O 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 297 KB

Combination therapy with interferon-α an

Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C

✍ Norio Horiike; Morikazu Onji 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 132 KB

Treatment of children with chronic hepat

Treatment of children with chronic hepatitis C with recombinant interferon-α: A pilot study

✍ Mercedes Ruiz-Moreno; Maria José Rua; Inmaculada Castillo; Maria Dolores García- 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

Twelve children with chronic non-A, non-B hepatitis were entered in a pilot trial of recombinant interferon-alpha. Although all the children had hepatitis C virus RNA in serum, only five had antibodies against this virus. Children received 3 MU/m2 body surface area interferon-alpha 3 times/wk for 6

A pilot study of ribavirin therapy for c

A pilot study of ribavirin therapy for chronic hepatitis C

✍ Adrian M. di Bisceglie; Michiko Shindo; Tse-Ling Fong; Michael W. Fried; Mark G. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

Interferon-alpha therapy is of proven efficacy in chronic hepatitis C, but it is not universally effective and may be associated with intolerable side effects. Ribavirin is a nucleoside analog with a broad spectrum of antiviral action. We conducted an uncontrolled pilot study of ribavirin therapy in

Limitation of combination therapy of int

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

✍ Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to clarify the effect of patient age on the efficacy a